QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
All India Institute of Ayurveda hosts ministers and showcase their achievements
The transaction is expected to close in the Q4FY22
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India
The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age
Subscribe To Our Newsletter & Stay Updated